An Outpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Adjunctive Treatment Of Sub-Optimally Controlled Symptoms of Schizophrenia
Clinical trial NCT01939548 · TERMINATED
Trial details
- NCT number
- NCT01939548
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2014-10-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.